Literature DB >> 11313904

Protease activated receptors: theme and variations.

P J O'Brien1, M Molino, M Kahn, L F Brass.   

Abstract

The four PAR family members are G protein coupled receptors that are normally activated by proteolytic exposure of an occult tethered ligand. Three of the family members are thrombin receptors. The fourth (PAR2) is not activated by thrombin, but can be activated by other proteases, including trypsin, tryptase and Factor Xa. This review focuses on recent information about the manner in which signaling through these receptors is initiated and terminated, including evidence for inter- as well as intramolecular modes of activation, and continuing efforts to identify additional, biologically-relevant proteases that can activate PAR family members.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313904     DOI: 10.1038/sj.onc.1204194

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

Review 1.  Platelet biology and receptor pathways.

Authors:  Giovanni Cimmino; Paolo Golino
Journal:  J Cardiovasc Transl Res       Date:  2013-01-10       Impact factor: 4.132

2.  Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.

Authors:  Leila M Sevigny; Karyn M Austin; Ping Zhang; Shogo Kasuda; Georgios Koukos; Sheida Sharifi; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

3.  Implanted cell-dense prevascularized tissues develop functional vasculature that supports reoxygenation after thrombosis.

Authors:  Sean M White; Chelsea R Pittman; Ryan Hingorani; Rajan Arora; Tatiana V Esipova; Sergei A Vinogradov; Christopher C W Hughes; Bernard Choi; Steven C George
Journal:  Tissue Eng Part A       Date:  2014-06-30       Impact factor: 3.845

4.  Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization.

Authors:  May M Paing; Christopher A Johnston; David P Siderovski; Joann Trejo
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Periodontal treatment downregulates protease-activated receptor 2 in human gingival crevicular fluid cells.

Authors:  Vanessa Tubero Euzebio Alves; Henrique Aparecido Bueno da Silva; Bruno Nunes de França; Rosangela Santos Eichler; Luciana Saraiva; Maria Helena Catelli de Carvalho; Marinella Holzhausen
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

6.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

7.  Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro.

Authors:  Barden Chan; Vikas P Sukhatme
Journal:  Thromb Res       Date:  2008-09-03       Impact factor: 3.944

Review 8.  Platelet thrombin receptor antagonism and atherothrombosis.

Authors:  Dominick J Angiolillo; Davide Capodanno; Shinya Goto
Journal:  Eur Heart J       Date:  2009-11-30       Impact factor: 29.983

9.  Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.

Authors:  Laith Altaweel; Daniel Sweeney; Xizhong Cui; Amisha Barochia; Charles Natanson; Peter Q Eichacker
Journal:  Biologics       Date:  2009-09-15

10.  Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Authors:  Vladislava O Melnikova; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Microenviron       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.